SlideShare une entreprise Scribd logo

Legal requirements for generics and abridged products and bioequivalence

•
•
I
inemet

This document summarizes key concepts related to legal requirements for generic and abridged drug products, including definitions, regulations, bioequivalence, and pros and cons of generic drugs. It discusses definitions of innovator products, generic medicines, pharmaceutical equivalence and alternatives. It also covers requirements for generic drug applications, marketing authorizations, and the need to demonstrate bioequivalence to the reference product through appropriate studies. Guidelines for bioavailability and bioequivalence studies from regulatory authorities are mentioned.

BusinessActualités & Politique
1  sur  42
Legal Requirements for Generics and Abridged Products and Bioequivalence I.Kanzik IDE PharmaConsult PharmaCon 2007 May 22 – 27, 2007 DUBROVNIK, Hotel Dubrovnik Palace
TOPICS ,[object Object],[object Object],[object Object],[object Object]
Career in Pharmacy ,[object Object],[object Object],[object Object]
Pharmaceutical Industry ,[object Object]
Regulatory Affairs ,[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object]
Three important requirements for Registration of NCE ,[object Object],[object Object],[object Object]
I nnovator P roduct ,[object Object]
Marketing Authorization I nnovator product ,[object Object],[object Object],[object Object],[object Object]
Drug Registration ,[object Object]
International Conference on Harmonisation ,[object Object]
EU Regulations ,[object Object]
2004/27/EC: Article 10.1: Reference and Generic Products ,[object Object]
Generic Medicines ,[object Object]
GENERIC APLICATIONS CONTENT OF THE FILE ,[object Object],[object Object],[object Object],[object Object]
Marketing Authorisation Generics ,[object Object],[object Object]
Essentially similar products European Court of Justice ,[object Object]
Essentially similar products ,[object Object]
[object Object]
ECJ Case C-74/03 of January 2005: Active Substance in Different Forms of Salt ,[object Object],[object Object],[object Object],[object Object],[object Object]
Article 10a: Well Established Medicinal Use ,[object Object],[object Object]
Generic drugs Bioequivalence ,[object Object],[object Object]
GENERIC APLICATIONS ,[object Object]
Pharmaceutical Equivalence ,[object Object],[object Object],[object Object]
Pharmaceutical Alternatives ,[object Object],[object Object]
Therapeutic E quivalence ,[object Object],[object Object],[object Object],[object Object],[object Object]
BIOAVAILABILITY (according to EU guidance note) ,[object Object]
BIOEQUIVALENCE (according to EU guidance note) ,[object Object]
[object Object],[object Object]
[object Object],[object Object]
Bioavailability/Bioequivalence Guidelines ,[object Object]
Global harmonisation ,[object Object],[object Object]
Differences among the authorities ,[object Object],[object Object]
[object Object]
Pros of generic drugs ,[object Object]
Cons of generic drugs ,[object Object]
Cons of generic drugs ,[object Object]
Cons of generic drugs ,[object Object],[object Object]
[object Object]
Substitution ,[object Object],[object Object]
[object Object]

Recommandé

ANDA
ANDAANDA
ANDASiddu K M
 
bioavailability and bioequivalence
bioavailability and bioequivalencebioavailability and bioequivalence
bioavailability and bioequivalencealviya thomas
 
Adverse Event reporting in Medical Device Clinical Trials under the MDR
Adverse Event reporting in Medical Device Clinical Trials under the MDRAdverse Event reporting in Medical Device Clinical Trials under the MDR
Adverse Event reporting in Medical Device Clinical Trials under the MDRAnnet Visscher
 
Parameters to evaluate Bioequivalence
Parameters to evaluate BioequivalenceParameters to evaluate Bioequivalence
Parameters to evaluate BioequivalenceVinitha Nair
 
Anda
AndaAnda
AndaMalla Reddy College of Pharmacy
 
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA sandeep bansal
 
Bioavilability and Bioequivalence study designs
Bioavilability and Bioequivalence study designsBioavilability and Bioequivalence study designs
Bioavilability and Bioequivalence study designsRajendra Mahajan Mr.Rajmahajan_9990
 
Brazil Cosmetics Regulations by Artixio
Brazil Cosmetics Regulations by ArtixioBrazil Cosmetics Regulations by Artixio
Brazil Cosmetics Regulations by ArtixioAndyThomas119
 

Recommandé

ANDA
ANDAANDA
ANDASiddu K M
 
bioavailability and bioequivalence
bioavailability and bioequivalencebioavailability and bioequivalence
bioavailability and bioequivalencealviya thomas
 
Adverse Event reporting in Medical Device Clinical Trials under the MDR
Adverse Event reporting in Medical Device Clinical Trials under the MDRAdverse Event reporting in Medical Device Clinical Trials under the MDR
Adverse Event reporting in Medical Device Clinical Trials under the MDRAnnet Visscher
 
Parameters to evaluate Bioequivalence
Parameters to evaluate BioequivalenceParameters to evaluate Bioequivalence
Parameters to evaluate BioequivalenceVinitha Nair
 
Anda
AndaAnda
AndaMalla Reddy College of Pharmacy
 
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA sandeep bansal
 
Bioavilability and Bioequivalence study designs
Bioavilability and Bioequivalence study designsBioavilability and Bioequivalence study designs
Bioavilability and Bioequivalence study designsRajendra Mahajan Mr.Rajmahajan_9990
 
Brazil Cosmetics Regulations by Artixio
Brazil Cosmetics Regulations by ArtixioBrazil Cosmetics Regulations by Artixio
Brazil Cosmetics Regulations by ArtixioAndyThomas119
 
EU guideline.pptx
EU guideline.pptxEU guideline.pptx
EU guideline.pptxEasy Concept
 
cGMP.pptx
cGMP.pptxcGMP.pptx
cGMP.pptxShiva Kant Thakur
 
Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Surendra Singh
 
The introduction of an orange book
The introduction of an orange bookThe introduction of an orange book
The introduction of an orange bookindus university-icri
 
EUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptxEUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptxPrachiSharma575050
 
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA) Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA) SachinRajput94
 
Regulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packgingRegulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packgingvineet gupta
 
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)RaghaviPillai
 
Principles of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentPrinciples of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentMANIKANDAN V
 
Guidelines for stability testing of herbal drugs
Guidelines for stability testing of herbal drugsGuidelines for stability testing of herbal drugs
Guidelines for stability testing of herbal drugsEasy Concept
 
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchCenter for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchRajeswariS12
 
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCSBIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCSChinmayaSahoo28
 
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIESREGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIESDhruvi Panchal
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validationDevipriya Viswambharan
 
Ich q8 ppt
Ich q8 pptIch q8 ppt
Ich q8 pptPalakdeep kaur(Parmeshar)
 
Ich guidelines
Ich guidelinesIch guidelines
Ich guidelineshimanshu kamboj
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 
Drug product performance
Drug product performanceDrug product performance
Drug product performanceVivekBihania
 
Quality by Design
Quality by DesignQuality by Design
Quality by DesignAshwani Dhingra
 
Ipqc tests for sterile formulations
Ipqc tests for sterile formulationsIpqc tests for sterile formulations
Ipqc tests for sterile formulationsPramod Ramane
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesDr. Kunal Chitnis
 
C 5 dosage form design
C 5 dosage form designC 5 dosage form design
C 5 dosage form designNadia Akhter
 

Contenu connexe

Tendances

Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Surendra Singh
 
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA) Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA) SachinRajput94
 
Regulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packgingRegulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packgingvineet gupta
 
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)RaghaviPillai
 
Principles of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentPrinciples of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentMANIKANDAN V
 
Guidelines for stability testing of herbal drugs
Guidelines for stability testing of herbal drugsGuidelines for stability testing of herbal drugs
Guidelines for stability testing of herbal drugsEasy Concept
 
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchCenter for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchRajeswariS12
 
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCSBIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCSChinmayaSahoo28
 
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIESREGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIESDhruvi Panchal
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 
Drug product performance
Drug product performanceDrug product performance
Drug product performanceVivekBihania
 
Ipqc tests for sterile formulations
Ipqc tests for sterile formulationsIpqc tests for sterile formulations
Ipqc tests for sterile formulationsPramod Ramane
 

Tendances (20)

EU guideline.pptx
EU guideline.pptxEU guideline.pptx
EU guideline.pptx
 
cGMP.pptx
cGMP.pptxcGMP.pptx
cGMP.pptx
 
Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)Ich guidelines Q1A(R2)
Ich guidelines Q1A(R2)
 
The introduction of an orange book
The introduction of an orange bookThe introduction of an orange book
The introduction of an orange book
 
EUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptxEUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptx
 
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA) Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
 
Regulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packgingRegulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packging
 
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
 
Principles of Drug Discovery and Development
Principles of Drug Discovery and DevelopmentPrinciples of Drug Discovery and Development
Principles of Drug Discovery and Development
 
Guidelines for stability testing of herbal drugs
Guidelines for stability testing of herbal drugsGuidelines for stability testing of herbal drugs
Guidelines for stability testing of herbal drugs
 
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchCenter for Biologics Evaluation and Research
Center for Biologics Evaluation and Research
 
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCSBIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
 
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIESREGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Ich q8 ppt
Ich q8 pptIch q8 ppt
Ich q8 ppt
 
Ich guidelines
Ich guidelinesIch guidelines
Ich guidelines
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 
Drug product performance
Drug product performanceDrug product performance
Drug product performance
 
Quality by Design
Quality by DesignQuality by Design
Quality by Design
 
Ipqc tests for sterile formulations
Ipqc tests for sterile formulationsIpqc tests for sterile formulations
Ipqc tests for sterile formulations
 

En vedette

Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesDr. Kunal Chitnis
 
C 5 dosage form design
C 5 dosage form designC 5 dosage form design
C 5 dosage form designNadia Akhter
 
Bioequivalence – Still a Quality Achilles’ Heel? 16 October 2014
Bioequivalence – Still a Quality Achilles’ Heel? 16 October 2014Bioequivalence – Still a Quality Achilles’ Heel? 16 October 2014
Bioequivalence – Still a Quality Achilles’ Heel? 16 October 2014Ajaz Hussain
 
Physicochemical and biological properties of sustained release formulations
Physicochemical and biological properties of sustained release formulationsPhysicochemical and biological properties of sustained release formulations
Physicochemical and biological properties of sustained release formulationsSonam Gandhi
 
ICH Q8 " PHARMACEUTICAL DEVELOPMENT"
ICH Q8 " PHARMACEUTICAL DEVELOPMENT"ICH Q8 " PHARMACEUTICAL DEVELOPMENT"
ICH Q8 " PHARMACEUTICAL DEVELOPMENT"Talha Mahmood
 
Vaccination challenging the community
Vaccination challenging the communityVaccination challenging the community
Vaccination challenging the communityPPPKAM
 
The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...inemet
 
Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms Dr Gajanan Sanap
 
Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.Muavia Sarwar
 
Rational drug design
Rational drug designRational drug design
Rational drug designNaresh Juttu
 
Quality by-Design (QbD) by Mr. Nitin Kadam.
Quality by-Design (QbD) by Mr. Nitin Kadam.Quality by-Design (QbD) by Mr. Nitin Kadam.
Quality by-Design (QbD) by Mr. Nitin Kadam.Nitin Kadam
 
Controlled drug delivery system
Controlled drug delivery systemControlled drug delivery system
Controlled drug delivery systemDanish Kurien
 
Jishnu organiations study at pvs hospital
Jishnu organiations study at pvs hospitalJishnu organiations study at pvs hospital
Jishnu organiations study at pvs hospitalLibu Thomas
 
Bioequivalence studies
Bioequivalence studiesBioequivalence studies
Bioequivalence studiesSujit Patel
 
Community Pharmacy
Community PharmacyCommunity Pharmacy
Community PharmacyKiran Sharma
 

En vedette (20)

Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence Studies
 
C 5 dosage form design
C 5 dosage form designC 5 dosage form design
C 5 dosage form design
 
Bioequivalence – Still a Quality Achilles’ Heel? 16 October 2014
Bioequivalence – Still a Quality Achilles’ Heel? 16 October 2014Bioequivalence – Still a Quality Achilles’ Heel? 16 October 2014
Bioequivalence – Still a Quality Achilles’ Heel? 16 October 2014
 
Physicochemical and biological properties of sustained release formulations
Physicochemical and biological properties of sustained release formulationsPhysicochemical and biological properties of sustained release formulations
Physicochemical and biological properties of sustained release formulations
 
ICH Q8 " PHARMACEUTICAL DEVELOPMENT"
ICH Q8 " PHARMACEUTICAL DEVELOPMENT"ICH Q8 " PHARMACEUTICAL DEVELOPMENT"
ICH Q8 " PHARMACEUTICAL DEVELOPMENT"
 
Vaccination challenging the community
Vaccination challenging the communityVaccination challenging the community
Vaccination challenging the community
 
The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...
 
Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms
 
Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.
 
Rational drug design
Rational drug designRational drug design
Rational drug design
 
Quality by-Design (QbD) by Mr. Nitin Kadam.
Quality by-Design (QbD) by Mr. Nitin Kadam.Quality by-Design (QbD) by Mr. Nitin Kadam.
Quality by-Design (QbD) by Mr. Nitin Kadam.
 
Controlled drug delivery system
Controlled drug delivery systemControlled drug delivery system
Controlled drug delivery system
 
Jishnu organiations study at pvs hospital
Jishnu organiations study at pvs hospitalJishnu organiations study at pvs hospital
Jishnu organiations study at pvs hospital
 
Bioequivalence studies
Bioequivalence studiesBioequivalence studies
Bioequivalence studies
 
Bioavailability Studies
Bioavailability StudiesBioavailability Studies
Bioavailability Studies
 
Community pharmacy
Community pharmacyCommunity pharmacy
Community pharmacy
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
 
Quality by Design
Quality by DesignQuality by Design
Quality by Design
 
Community Pharmacy
Community PharmacyCommunity Pharmacy
Community Pharmacy
 
Computer Aided Drug Design ppt
Computer Aided Drug Design pptComputer Aided Drug Design ppt
Computer Aided Drug Design ppt
 

Similaire à Legal requirements for generics and abridged products and bioequivalence

Bioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfallsBioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfallsinemet
 
Biologicals and biosimilars a review of the science and its implications
Biologicals and biosimilars a review of the science and its implicationsBiologicals and biosimilars a review of the science and its implications
Biologicals and biosimilars a review of the science and its implicationsNational Institute of Biologics
 
Pharmaceutical Industry Terminology
Pharmaceutical Industry TerminologyPharmaceutical Industry Terminology
Pharmaceutical Industry TerminologyThomson Reuters
 
Bio-equivalence and Bio-similarity studies of Drugs
Bio-equivalence and Bio-similarity studies of DrugsBio-equivalence and Bio-similarity studies of Drugs
Bio-equivalence and Bio-similarity studies of DrugsMd. Zakaria Faruki
 
Generic Drugs Michael Mc Namara May 12
Generic Drugs Michael Mc Namara May 12Generic Drugs Michael Mc Namara May 12
Generic Drugs Michael Mc Namara May 12MichaelMcNamara
 
regulatory concepts endfkadflsdjfajfd.ppt
regulatory concepts endfkadflsdjfajfd.pptregulatory concepts endfkadflsdjfajfd.ppt
regulatory concepts endfkadflsdjfajfd.pptomkarborlepwar2002
 
pharma regulatory a
pharma regulatory apharma regulatory a
pharma regulatory aswapy123
 
Brand drug vs generic drug
Brand drug vs generic drugBrand drug vs generic drug
Brand drug vs generic drugShubham Paul
 
Combination Products
Combination ProductsCombination Products
Combination Productschemist874
 
GENERIC DRUG DEVELOPMENT AND THERAPEUTIC EQUIVALENCE
GENERIC DRUG DEVELOPMENT AND THERAPEUTIC EQUIVALENCEGENERIC DRUG DEVELOPMENT AND THERAPEUTIC EQUIVALENCE
GENERIC DRUG DEVELOPMENT AND THERAPEUTIC EQUIVALENCEPUNIT PANDEY
 
EFFICACY OF HERBAL PRODUCTS
EFFICACY OF HERBAL PRODUCTS EFFICACY OF HERBAL PRODUCTS
EFFICACY OF HERBAL PRODUCTS Sarvan Mani
 
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14Holly Groelle
 
Biosimilars
BiosimilarsBiosimilars
BiosimilarsVINOTH R
 

Similaire à Legal requirements for generics and abridged products and bioequivalence (20)

Bioequivalence
BioequivalenceBioequivalence
Bioequivalence
 
Regulatory Perspectives on Biosimilars in Europe
Regulatory Perspectives on Biosimilars in EuropeRegulatory Perspectives on Biosimilars in Europe
Regulatory Perspectives on Biosimilars in Europe
 
Bioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfallsBioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfalls
 
Biologicals and biosimilars a review of the science and its implications
Biologicals and biosimilars a review of the science and its implicationsBiologicals and biosimilars a review of the science and its implications
Biologicals and biosimilars a review of the science and its implications
 
Pharmaceutical Industry Terminology
Pharmaceutical Industry TerminologyPharmaceutical Industry Terminology
Pharmaceutical Industry Terminology
 
Bio-equivalence and Bio-similarity studies of Drugs
Bio-equivalence and Bio-similarity studies of DrugsBio-equivalence and Bio-similarity studies of Drugs
Bio-equivalence and Bio-similarity studies of Drugs
 
Generic Drugs Michael Mc Namara May 12
Generic Drugs Michael Mc Namara May 12Generic Drugs Michael Mc Namara May 12
Generic Drugs Michael Mc Namara May 12
 
regulatory concepts endfkadflsdjfajfd.ppt
regulatory concepts endfkadflsdjfajfd.pptregulatory concepts endfkadflsdjfajfd.ppt
regulatory concepts endfkadflsdjfajfd.ppt
 
Bioequivalence study.pdf
Bioequivalence study.pdfBioequivalence study.pdf
Bioequivalence study.pdf
 
pharma regulatory a
pharma regulatory apharma regulatory a
pharma regulatory a
 
Swapnil2
Swapnil2Swapnil2
Swapnil2
 
Biosimilar - a mAb case study
Biosimilar - a mAb case studyBiosimilar - a mAb case study
Biosimilar - a mAb case study
 
Brand drug vs generic drug
Brand drug vs generic drugBrand drug vs generic drug
Brand drug vs generic drug
 
Circular 07/2022/TT-BYT: ON PHAMARCEUTICAL PRODUCTS FOR WHICH IN VIVO BIOEQUI...
Circular 07/2022/TT-BYT: ON PHAMARCEUTICAL PRODUCTS FOR WHICH IN VIVO BIOEQUI...Circular 07/2022/TT-BYT: ON PHAMARCEUTICAL PRODUCTS FOR WHICH IN VIVO BIOEQUI...
Circular 07/2022/TT-BYT: ON PHAMARCEUTICAL PRODUCTS FOR WHICH IN VIVO BIOEQUI...
 
Combination Products
Combination ProductsCombination Products
Combination Products
 
GENERIC DRUG DEVELOPMENT AND THERAPEUTIC EQUIVALENCE
GENERIC DRUG DEVELOPMENT AND THERAPEUTIC EQUIVALENCEGENERIC DRUG DEVELOPMENT AND THERAPEUTIC EQUIVALENCE
GENERIC DRUG DEVELOPMENT AND THERAPEUTIC EQUIVALENCE
 
EFFICACY OF HERBAL PRODUCTS
EFFICACY OF HERBAL PRODUCTS EFFICACY OF HERBAL PRODUCTS
EFFICACY OF HERBAL PRODUCTS
 
ASEAN_BE_Guidelines.pdf
ASEAN_BE_Guidelines.pdfASEAN_BE_Guidelines.pdf
ASEAN_BE_Guidelines.pdf
 
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 

Plus de inemet

EUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical SciencesEUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical Sciencesinemet
 
Significance of BA/BE studies in drug research and evaluation of different as...
Significance of BA/BE studies in drug research and evaluation of different as...Significance of BA/BE studies in drug research and evaluation of different as...
Significance of BA/BE studies in drug research and evaluation of different as...inemet
 
The role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalenceThe role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalenceinemet
 
Future trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyFuture trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyinemet
 
Focussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughFocussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughinemet
 
Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?inemet
 
Education - Do we have a choice?
Education - Do we have a choice?Education - Do we have a choice?
Education - Do we have a choice?inemet
 
BY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUEBY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUEinemet
 
POSTGENETICS MEDICINE
POSTGENETICS MEDICINEPOSTGENETICS MEDICINE
POSTGENETICS MEDICINEinemet
 
SHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERSSHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERSinemet
 
Sightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forwardSightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forwardinemet
 
EU telematics in the regulation of pharmaceuticals
EU telematics in the regulation of pharmaceuticalsEU telematics in the regulation of pharmaceuticals
EU telematics in the regulation of pharmaceuticalsinemet
 
Generics and Biogenerics
Generics and BiogenericsGenerics and Biogenerics
Generics and Biogenericsinemet
 
Pharmacovigilance Workshop
Pharmacovigilance WorkshopPharmacovigilance Workshop
Pharmacovigilance Workshopinemet
 
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...inemet
 
Making knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency MapsMaking knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency Mapsinemet
 
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats inemet
 
Pharmacy in croatia - A short overview
Pharmacy in croatia - A short overviewPharmacy in croatia - A short overview
Pharmacy in croatia - A short overviewinemet
 
Pharmacy Global Track(s)
Pharmacy Global Track(s)Pharmacy Global Track(s)
Pharmacy Global Track(s)inemet
 
EPSA Vision Of Pharmacy
EPSA Vision Of PharmacyEPSA Vision Of Pharmacy
EPSA Vision Of Pharmacyinemet
 

Plus de inemet (20)

EUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical SciencesEUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical Sciences
 
Significance of BA/BE studies in drug research and evaluation of different as...
Significance of BA/BE studies in drug research and evaluation of different as...Significance of BA/BE studies in drug research and evaluation of different as...
Significance of BA/BE studies in drug research and evaluation of different as...
 
The role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalenceThe role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalence
 
Future trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyFuture trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnology
 
Focussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughFocussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enough
 
Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?
 
Education - Do we have a choice?
Education - Do we have a choice?Education - Do we have a choice?
Education - Do we have a choice?
 
BY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUEBY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUE
 
POSTGENETICS MEDICINE
POSTGENETICS MEDICINEPOSTGENETICS MEDICINE
POSTGENETICS MEDICINE
 
SHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERSSHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERS
 
Sightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forwardSightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forward
 
EU telematics in the regulation of pharmaceuticals
EU telematics in the regulation of pharmaceuticalsEU telematics in the regulation of pharmaceuticals
EU telematics in the regulation of pharmaceuticals
 
Generics and Biogenerics
Generics and BiogenericsGenerics and Biogenerics
Generics and Biogenerics
 
Pharmacovigilance Workshop
Pharmacovigilance WorkshopPharmacovigilance Workshop
Pharmacovigilance Workshop
 
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
 
Making knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency MapsMaking knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency Maps
 
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats
 
Pharmacy in croatia - A short overview
Pharmacy in croatia - A short overviewPharmacy in croatia - A short overview
Pharmacy in croatia - A short overview
 
Pharmacy Global Track(s)
Pharmacy Global Track(s)Pharmacy Global Track(s)
Pharmacy Global Track(s)
 
EPSA Vision Of Pharmacy
EPSA Vision Of PharmacyEPSA Vision Of Pharmacy
EPSA Vision Of Pharmacy
 

Dernier

(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607dollysharma2066
 
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...lizamodels9
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckHajeJanKamps
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfJos Voskuil
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessSeta Wicaksana
 
Keppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation SlidesKeppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation SlidesKeppelCorporation
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Seta Wicaksana
 
The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024christinemoorman
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Riya Pathan
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Kirill Klimov
 
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...lizamodels9
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCRashishs7044
 
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Servicecallgirls2057
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCRashishs7044
 
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,noida100girls
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesKeppelCorporation
 

Dernier (20)

(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
 
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deckPitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
Pitch Deck Teardown: Geodesic.Life's $500k Pre-seed deck
 
Corporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information TechnologyCorporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information Technology
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdf
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful Business
 
Keppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation SlidesKeppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation Slides
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...
 
The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024
 
Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737Independent Call Girls Andheri Nightlaila 9967584737
Independent Call Girls Andheri Nightlaila 9967584737
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024
 
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
 
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
 
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Greater Noida ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation Slides
 

Legal requirements for generics and abridged products and bioequivalence

  • 1. Legal Requirements for Generics and Abridged Products and Bioequivalence I.Kanzik IDE PharmaConsult PharmaCon 2007 May 22 – 27, 2007 DUBROVNIK, Hotel Dubrovnik Palace
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.